CDK6 and acute myeloid leukemia: Notably, AML patients with the highest CDK6-AS1 levels were at high risk of not achieving complete remission, and also had elevated expression of mitochondrial translation-related genes, while being negatively enriched in genes regulated by RUNX1, an essential factor for the early hematopoietic differentiation process.